CRBU
Price
$0.79
Change
+$0.03 (+3.95%)
Updated
May 8, 04:59 PM (EDT)
Capitalization
70.68M
5 days until earnings call
EDIT
Price
$1.39
Change
+$0.06 (+4.51%)
Updated
May 8 closing price
Capitalization
111.33M
3 days until earnings call
Ad is loading...

CRBU vs EDIT

Header iconCRBU vs EDIT Comparison
Open Charts CRBU vs EDITBanner chart's image
Caribou Biosciences
Price$0.79
Change+$0.03 (+3.95%)
Volume$15.72K
Capitalization70.68M
Editas Medicine
Price$1.39
Change+$0.06 (+4.51%)
Volume$1.95M
Capitalization111.33M
CRBU vs EDIT Comparison Chart
Loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBU vs. EDIT commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Hold and EDIT is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (CRBU: $0.76 vs. EDIT: $1.39)
Brand notoriety: CRBU and EDIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 43% vs. EDIT: 89%
Market capitalization -- CRBU: $70.68M vs. EDIT: $111.33M
CRBU [@Biotechnology] is valued at $70.68M. EDIT’s [@Biotechnology] market capitalization is $111.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileEDIT’s FA Score has 1 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • EDIT’s FA Score: 1 green, 4 red.
According to our system of comparison, EDIT is a better buy in the long-term than CRBU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 5 TA indicator(s) are bullish while EDIT’s TA Score has 4 bullish TA indicator(s).

  • CRBU’s TA Score: 5 bullish, 3 bearish.
  • EDIT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than EDIT.

Price Growth

CRBU (@Biotechnology) experienced а -10.68% price change this week, while EDIT (@Biotechnology) price change was -14.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.88%. For the same industry, the average monthly price growth was +15.29%, and the average quarterly price growth was -13.75%.

Reported Earning Dates

CRBU is expected to report earnings on Aug 12, 2025.

EDIT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (-3.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDIT($111M) has a higher market cap than CRBU($70.7M). EDIT YTD gains are higher at: 9.449 vs. CRBU (-52.201). CRBU has higher annual earnings (EBITDA): -162.69M vs. EDIT (-233.11M). EDIT has more cash in the bank: 270M vs. CRBU (210M). CRBU has less debt than EDIT: CRBU (26.5M) vs EDIT (35M). EDIT has higher revenues than CRBU: EDIT (32.3M) vs CRBU (9.99M).
CRBUEDITCRBU / EDIT
Capitalization70.7M111M64%
EBITDA-162.69M-233.11M70%
Gain YTD-52.2019.449-552%
P/E RatioN/AN/A-
Revenue9.99M32.3M31%
Total Cash210M270M78%
Total Debt26.5M35M76%
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUEDIT
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 15 days ago
77%
Bullish Trend 17 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Ad is loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HALO70.1410.76
+18.12%
Halozyme Therapeutics
GRND24.030.67
+2.87%
Grindr
INTU641.1414.59
+2.33%
Intuit
PYXS1.07N/A
N/A
Pyxis Oncology
ZVRA7.51-0.49
-6.12%
Zevra Therapeutics

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CCCC. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
+0.76%
CCCC - CRBU
55%
Loosely correlated
+6.38%
CRSP - CRBU
53%
Loosely correlated
+3.29%
FATE - CRBU
51%
Loosely correlated
+4.41%
ALLO - CRBU
51%
Loosely correlated
-6.25%
AXON - CRBU
50%
Loosely correlated
+0.02%
More